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Thenonobese diabetic (NOD)mouse represents awell-established experimentalmodel analogous to human type 1 diabetesmellitus
(T1D) as it is characterized by progressive autoimmune destruction of pancreatic 𝛽-cells. Experiments were designed to investigate
the impact of moderate-intensity training on T1D immunomodulation and inflammation. Under a chronic exercise regime, NOD
mice were trained on a treadmill for 12 weeks (12m/min for 30min, 5 d/wk) while age-matched, control animals were left untrained.
Prior to and upon completion of the training period, fed plasma glucose and immunological soluble factors were monitored. Both
groups showed deteriorated glycemic profiles throughout the study although trained mice tended to be more compensated than
controls after 10weeks of training. An exercise-inducedweight losswas detected in the trainedmicewith respect to the controls from
week 6.After 12weeks, IL-6 andMIP-1𝛽were decreased in the trained animals compared to their baseline values and versus controls,
although not significantly. Morphometric analysis of pancreata revealed the presence of larger infiltrates along with decreased 𝛼-
cells areas in the control mice compared to trained mice. Exercise may exert positive immunomodulation of systemic functions
with respect to both T1D and inflammation, but only in a stringent therapeutic window.
1. Introduction
Type 1 diabetes (T1D) is an autoimmune disease in which the
immune system is activated against the insulin producing 𝛽-
cells present in the pancreatic islets [1]. The elimination of
these cells impairs the mechanisms that control the glucose
blood level and, up to now, the possible and most efficacious
treatment for T1D is based on insulin administration and
pancreas or pancreatic islet transplantation [2, 3]. While
exercise represents a cornerstone in the treatment and
prevention of type 2 diabetes mellitus, only recently its
effects on glycemic profile and autoimmunity in T1D have
been debated by several studies, due to the controversial
data reported regarding the benefits of supervised exercise
training on metabolic control in people with T1D [4, 5].
In fact, managing blood glucose in T1D while exercising
is complex and involves multiple factors such as type of
insulin used, time between food intake and sport activity,
duration, and intensity of physical effort, known to deter
people from enjoying the benefits of sport at both recreational
and competitive levels [6, 7]. Some speculative hypotheses
instead point at the positive immunomodulatory effect of
exercise with respect to both T1D and inflammation [8, 9].
Oresˇicˇ et al. showed how metabolic dysregulation precedes
the autoimmune attack against𝛽-cells and suggested lifestyles
modification as front-line prevention strategy [10]. During
exercise, skeletal muscle releases myokines (IL-6) and the
subsequent production of IL-1 receptor antagonist (IL-1ra)
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by monocytes and macrophages may frame a potent anti-
inflammatory window [11].
There are several studies investigating the effects of
exercise in inbred rodents with naturally occurring type 2
diabetes or streptozotocin-induced diabetes [12, 13]; however,
few studies have been conducted in a NOD mouse model
which spontaneously develops T1D [14–17] and resembles the
disease progression in humans. By using the NODmodel, we
tested the effect of moderate-intensity exercise in inducing
immunological changes that would result in the delay of
T1D progression. In particular, we analyzed the differences in
cytokine profiles between trained and untrained animals and
correlated these modulations with T1D appearance.
2. Material and Methods
2.1. Animals and Training. Eight-week-old female NODmice
(Jackson Laboratory) were first acclimated to a six-lane tread-
mill (Columbus, OH) by running for 10min at 10m/min fol-
lowed by 2min at 20m/min (0∘ slope), in three running ses-
sions over a week before exercise testing. Animals were then
trained on a treadmill following a chronic exercise regime
(30min/day, 5 days/week at the speed of 12m/min) for 12
weeks. Age-matched, control animals were left untrained.
Prior to and upon completion of the training period, mice
underwent muscular performance evaluation determined by
a submaximal incremental test (peak oxygen uptake (VO
2
)
challenge), as previously described [16]. To determine VO
2
peak, mice were placed in a treadmill for 5min at a 0∘ incline
and 0m/min. The NOD mice were then challenged with
1.5min intervals of increasing speed at a 15∘ incline. Nonfast-
ing glycemic levels of experimental mice were monitored 2-3
times a week using OneTouchUltra2 glucometers (Lifescan).
Animals were considered diabetic and euthanized upon 3
consecutive blood glucose readings above 300mg/dL.Animal
studies were performed in compliance with IACUC and the
US Department of Health and Human Services Guide for the
Care and Use of Laboratory Animals.
2.2. Cytokines Bead Assay. Cytokine profiles were evaluated
on the serum of the NOD mice before and after 8 weeks
of exercise training and upon completion of the 12-week
endurance training program. The serum content of G-CSF,
GM-CSF, IFN-𝛾, IL-1𝛽, IL-2, IL-4, IL-6, IL-10, IL-2p40, IL-
13, MCP-1, MIP-1𝛽, MIP-2, VEGF, and TNF-𝛼 was analyzed
simultaneously using the cytokine bead assay (Millipore) and
data were collected using the Luminex.
2.3. Immunohistochemistry and Images Acquisition. Pancreas
of 20-week-oldNODmice was collected and fixed in buffered
formalin 10% overnight at 4∘C and subsequently in opti-
mal cutting temperature (OCT, Tissue-Tek) compound and
frozen in dry ice. 5 𝜇m sections were obtained from the
cryopreserved blocks, permeabilized with 0.3% PBS Triton
X-100, then incubated in universal blocker reagent (Biogenex
San Raman CA) for 30min, and washed in Optimax wash
buffer (Biogenex). Sections were then incubated overnight
at 4∘C with guinea pig anti-insulin (Biogenex ready to use
polyclonal antibodies) and mouse antiglucagon (monoclonal
clone K79bB10 diluted at 1 : 1000, Sigma) primary antibodies
and for 1 hr at room temperature with goat anti-guinea pig
Alexa Fluor 488 (Invitrogen) and goat anti-mouse Alexa
Fluor 568 (Invitrogen) secondary antibodies diluted in wash
buffer at 1 : 300. As negative control samples, slides were incu-
bated with the preimmune serum from animal of the same
species instead of the primary antibody. DAPI (Invitrogen)
was used for nuclear staining and slides were mounted with
ProLongAntifade (Invitrogen). Pictures were acquired with a
Zeiss Axiovert 200M confocalmicroscope, accessorized with
a Hamamatsu camera, available at the imaging core facility of
the Diabetes Research Institute, University of Miami. Slides
analyzed at the University ofMilan were acquired withNikon
Eclipse 50I microscopy and images were captured using Nis-
Elements D 4.00 software (Nikon Instruments Europe BV,
Netherlands). Data were displayed and analyzed using Adobe
Photoshop CS4. A Scale bar 200 𝜇m or (20x) was used.
2.4. Automated Quantification. Quantification of cellular
composition (i.e., 𝛽-cells, 𝛼-cells, and nuclei) was per-
formed by using the cells count macrowritten for Image J
(http://imagej.nih.gov/ij/).
2.5. Statistical Analysis. Glucose profiles were shown as
median and quartiles given the nonparametric distribution
of the data, except where differently expressed. Muscular
performance data were presented as the mean ± SEM and 𝑡-
tests were used to calculate statistical significancy. Cytokines
were analyzed by a two-way ANOVAwith repeated measures
followed by Bonferroni’s post hoc test. Since the distribu-
tions of G-CSF, GM-CSF, and IL-10 showed deviations from
normality due to the presence of outliers, these cytokines
were subjected to logarithmic transformation prior to the
execution of ANOVA. Results were considered significant
when 𝑝 ≤ 0.05.
3. Results
3.1. Glucose Profiles. Deterioration of glycemic profile was
appreciable around the 10th week of training in all NODmice
under investigation, with slight lower glycemia in the exer-
cising mice with respect to the untrained ones (Figure 1(a)),
although the impact of diabetes was remarkable already at
week 6 in the trained mice, as indicated by the interquartiles
and the diabetic incidence. A similar pattern was detectable
among the diabetes-free mice (Figure 1(b)), with a better
glycemic profile in the NOD mice on training compared to
the controls. In the secondpart of the experiment, fromweeks
6 to 12 of training, among the diabetes-free mice, the average
glycemic values resulted in being significantly lower in the
trained animals with respect to the controls (110 ± 1.4 versus
116 ± 2mg/dL, means and SEM, 𝑝 < 0.05) (Figure 2).
3.2. BodyWeight. An exercise-induced weight loss was regis-
tered in the trainedmice after 6weeks of training as compared
to the sedentary mice (Figure 4(a), 𝑝 < 0.01). From week 7,
the exercising mice continued to weigh less than their age-
matched controls, and they remained leaner until the end of
the experiment (Figure 4(b), 𝑝 < 0.01).
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Figure 1: Glycemic profiles over the 12-week exercise training program in all NOD mice (a) and in diabetes-free NOD mice (b). In (a),
glycemic values are expressed as median and interquartiles, whereas in (b) data are shown as means and SEM.
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Figure 2: Average glycemic values in diabetes-free NODmice in the
time-window 6–12 weeks of training. Results are shown as means
and SEM.
3.3. Incidence. At training week 7, 4 out of 20 exercising mice
became diabetic and that reflected the diabetic incidence
percentage, although not significantly, between exercising
(10%) and control mice (3%) (Figure 3(a)). After 12 weeks
of training, diabetic incidence was 40% for both groups. In
detail, 2 out of 14 mice on training were diabetic, whereas,
among the controls, 5 out of 18 mice were diabetic. On
the other hand, a substantial number of animals remained
diabetes-free at the end of the experiment (12 trained mice
versus 13 controls) (Figure 2).
3.4. Survival. The survival rate declined progressively in both
groups, with no statistical difference between the exercising
mice (70%) and the controls (88%), upon completion of
the 12-week training program. This final rate was indirectly
linked to the early diabetic incidence occurring in the trained
mice, starting from week 7. In fact, those 4 mice that became
diabetic after 7 weeks of training died concurrently during
week 10. Overall, 6 mice of the exercising group died because
of diabetes; likewise 2 control mice faced the same fate.
3.5. Muscular Performance. A submaximal incremental run-
ning test was performed at baseline and upon completion of
the 12-week chronic training program to determine the acute
exercise capacity of the NODmice, putatively conditioned by
the endurance training per se and, above all, by the diabetes
progression. To evaluate this, we differentiated the results
coming from all NOD mice (trained versus controls, regard-
less of the diabetes diagnosis; Figures 5(a) and 5(c)) and those
arisen from the comparison on all diabetes-free NOD mice
(trained versus controls, without diabetes; Figures 5(b) and
5(d)). At the end of 12 weeks of training, maximal running
speed assessed during the submaximal test was found to be
significantly decreased in all NOD mice with respect to their
pretraining values (𝑝 < 0.05), whereas no difference was
found between trained and control animals when comparing
their posttraining values (Figure 5(a)). When diabetes-free
mice were compared, trained mice worsened their maximal
running speed at 12weekswith respect to their baseline values
(Figure 5(b), 𝑝 < 0.01). Similarly, a significant reduction
in the distance covered during the submaximal performance
test was also found in the NOD-exercising mice at week 12
with respect to their pretraining values (Figure 5(c), 𝑝 <
0.01) and the age-matched controls also (Figure 5(c), 𝑝 <
0.05). However, even the control mice deteriorated their
performance after 12 weeks as compared to the maximal
distance covered at baseline (Figure 5(c), 𝑝 < 0.05). A
significant decrease in the maximal distance was also found
in the diabetes-free trained mice at week 12 as compared to
week 0 (Figure 5(d), 𝑝 < 0.01).
3.6. Morphometric Analysis of Pancreata. Diabetes negatively
affected the morphology of the islets in both trained and
control groups. Typical islet from a diabetic exercising animal
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Figure 3: Incidence of type 1 diabetes (a) and survival (b) in all NOD mice.
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Figure 4: (a) Body weight throughout the 12-week training program. (b) Body weight difference at baseline and upon completion of the
12-week training program. Results are shown as means and SEM.
after 6 weeks of training is shown (Figure 6(a)) in the
pancreatic section triple stained for insulin, glucagon, and
nuclei. Immunostaining of pancreatic sections indicated the
presence of larger infiltrates in control mice, along with a
greater amount of 𝛼-cells in the NOD-exercising mice at the
end of the 12-week training program (Figures 6(b), 6(c), and
6(f); 𝑝 = 0.052). Pancreatic infiltrates were ubiquitously
detected in mice on training and controls, whereas no 𝛽-cells
were found at the end of the study in all diabetic mice.
3.7. Cytokines. Serum pro- and anti-inflammatory cytokines
measured at the baseline, after 8 weeks of training and at the
conclusion of the 12-week training program, fluctuated with
no statistical significance throughout the timeline in all NOD
mice (Figure 7). Only some cytokines seemed to be aligned
to an exercise-promoted anti-inflammatory pattern: IL-6 and
MIP-1𝛽 resulted in being lower, even though not significantly,
at the termination of the training program in the trained
animals compared to the sedentary controls, and with respect
to their pretraining values.
4. Discussion
With this in vivo approach, we wanted to evaluate how
physical activity as endurance training can contribute in
controlling T1D progression and analyzing the role played
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Figure 5: Muscular performance data: speed and distance obtained during a submaximal incremental running test, respectively, in all NOD
mice (a, c) and in diabetes-free NOD mice (b, d). Results are shown as means and SEM.
by exercise on the immune system. Preliminary studies have
shown the importance and impact of physical exercise on
controlling autoimmune diseases, by modulating different
immune parameters and components [11, 18–23]. Most stud-
ies on the effects of exercise on immunity have shown
that habitual, moderate-intensity training augments immune
responses by increasing the expression of proinflammatory
cytokines, including IL-2, IL-1𝛽, andTNF-𝛼, while exhaustive
exercise tends to be immunosuppressive [24–26]. On the
basis of our data, NOD mice appeared to be interesting for
the studying of insulin-dependent diabetes although they
remained a questionable model for running exercise studies
with high significance for the autoimmunity [27]. In fact,
in NOD mice, diabetogenesis is under complex polygenic
control and the penetrance of these polygenes is greatly con-
ditioned bywide disparate conditions (microbial and physical
environment, diet, etc.): some environmental pathogens may
even offer more protection to NOD mice against the T1D
onset, by the simple activation of their immune system [28].
In this perspective, our hypothesis to exploit the positive
stimulation of physical exercise was tricky to be challenged.
On a side, exercise, under adequate mild doses, would have
counteracted the activation of diabetogenic innate immune
responses or, at least, it would have exerted those preventive,
protective effects in T1D by decreasing oxidative stress and
preservation of 𝛽-cell integrity. However, there is incomplete
knowledge on how exercise acts in T1D, and therefore
physical activity could be as stressogenic as many other
6 Journal of Diabetes Research
(a)
(b)
(c)
(d)
(e)
0.5
1.0
1.5
0
𝛼
-c
el
ls/
in
fil
tr
at
e
Control Trained
p = 0.052
(f)
Figure 6: (a) Islet of Langerhans visualized by immunofluorescence microscopy.This figure is a representative immunostaining of pancreatic
sections, from a NOD diabetic mouse after 6 weeks of exercise. The entire tissue section is captured by a modified method of “virtual slice
image capture” using amicroscope with a 10x objective. Each virtual slice taken atmultiple fluorescent channels ismerged into one composite,
shown as insulin (green), glucagon (red), and DAPI for the nuclei. Quantitatively, the cell composition of these mouse islets was more than
70% 𝛽-cells and less than 20% 𝛼-cells. Analysis of the immune infiltrates (blue) in the pancreatic islets of diabetic untrained (b) or trained
(c) animals at 12th week of exercise (20x objective). (d, e) Analysis of the pancreatic islets of two mice died at week 10 of exercise because of
earlier diabetic incidence (occurred at 7th week of training) (20x objective). (f) Whiskers plot of the ratio 𝛼-cells/infiltrate in controls and
trained mice at the end of the 12 weeks of training.
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Figure 7: Continued.
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Figure 7: Fluctuations of the cytokines in all NODmice, throughout the entire duration of the 12-week endurance training program. Results
are shown as means and SEM (mfi = mean fluorescence intensity).
detrimental conditions for which NOD mice are highly
susceptible to develop diabetes. In our study, the design failed
to demonstrate a delay in the onset of T1D thanks to exercise;
on the contrary, an early diabetic incidence occurred in the
exercising group (𝑛 = 4) as early as week 7 of the training
program, although not significantly. Cumulative diabetic
incidence was though consistent with data of the literature,
confirming expected percentages of T1D penetrance in this
model [28].
Certainly, diabetes progression affected per se the exercise
capacity of the mice irrespective of the endurance training:
physical exercise represented an additional stress to the
NOD-exercising mice, even at moderate intensity. However,
thoseNODmice, able to tolerate the exercise stress, showed at
the same time a slightly ameliorated inflammatory metabolic
profile, one that may be contrasting the diabetes progression
and the inflammation attack toward the pancreatic islets.
Overall, exercise neither was able to modulate and control
the immune attack toward autologous 𝛽-cells even if initiated
prior to the T1D onset, nor had ability to rescue 𝛽-cells once
lost, in accordancewith previous studies [12, 13, 29]. However,
after 10 weeks of training, diabetic and nondiabetic trained
mice showed better glucose profiles than the control mice
(Figures 1 and 2).
Today the mechanisms by which exercise regulates
glycemia in a T1D context are still unclear. Previously, very
few studies documented the possibility to positively control
and lower blood glucose by means of exercise in T1D
animal models [30]. Some of them were designed on rat
models, using streptozotocin-induced diabetes, which rules
out autoimmunity, a leading feature resembling human T1D
[12, 13, 20, 29–31]. NOD-SCIDmicewere also studied because
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they do not develop T1D, since they do not have a functional
immune system. Other studies relied on exogenous insulin
treatments to reduce blood glucose, which provides disad-
vantageswhen interpreting data, because high glucose is toxic
to the islet cells, and glucotoxicity represents a biasing factor
[32, 33]. In the present study, NOD mice were not treated
with insulin. Exercise had glucose-lowering effects, reaching
statistical significance only in the late window of the observed
training period (Figures 1(a) and 2).
The significant reduction of blood glucose was paralleled
also in diabetes-free NOD mice, particularly when referring
to the mean glycemic values (Figures 1(b) and 2). This could
suggest a preserved ability by which exercise downregulates
blood glucose, in NOD mice, when the immune attack has
not led yet to frank diabetes, that is, by insulin-stimulated
glucose uptake in the skeletal muscle [34].
Over the 12-week study, both groups exihbited an
expected increase in body weight (+15–25%); however, from
week 6, exercising mice began to display significant reduc-
tions in body weight compared to controls (−15%) which
remained significantly lower (𝑝 < 0.01) at the termination of
the study, despite only a 1.4 g difference (Figure 4). Unfortu-
nately, we were not able to ascertain whether this discrepancy
was due to a simple exercise-induced leaner mass rather than
a more cachectic state: no visible signs or discomfort or stress
was though detected, except for polyuria in the diabetic mice.
A nonunivocal inflammatory pattern emerged from the
current analysis. In addition, the expression profiles of serum
inflammatory cytokines were not mirrored in the infiltrating
immune cells, which are important mediators for 𝛽-cell
demise in the NOD model [35]. Once precised, some of
the cytokines measured in the blood at the termination
of the study fluctuated in an anti-inflammatory fashion
(IL-6, MIP-1𝛽) in the trained mice compared to controls,
although without reaching statistical significance. Therefore,
these indications must be collected thoughtfully, especially
considering the lack of statistical confirmation. Besides,
other cytokines (IL-2, IL-4, and IL-10) seemed to act in a
proinflammatory way at the end of the study in the exercised
mice. However, the important anti-inflammatory cytokine
IL-10 was found higher in the serum of the trained mice
over the remainder of the study (until week 10) compared to
controls (Figure 7).
As to the inflammatory milieu in NOD mouse islets,
the morphological examination indicated a tendency for a
decreased estimate of infiltrates in the trainedmice alongwith
a greater amount of 𝛼-cell areas with respect to the diabetic
controls (Figure 6(f), 𝑝 = 0.052). Plesner et al. reported
the nonbeta islet endocrine cell remodeling in diabetic NOD
mice: that study suggested that infiltrating immune cells
may restrict alpha-cell expansion in NOD mouse islet in the
diabetic state [36]. Here, a greater alpha-cells-infiltrates ratio
was also found in the diabetic states of trainedmice sacrificed
at week 7 of our study (Figures 6(d) and 6(e)). Whether the
alpha-cell mass may be dependent on the stage of disease
remains to be ascertained. Moreover, it would be interesting
to understand when (and possibly to which extent) exercise
may represent a strategy tomaintain normal islet architecture
in diabetes. A further in-depth analysis is obviously required
to address this; however, a putative capability of the exercising
mice to oppose the diabetic deterioration that progressively
sacrifices 𝛽-cells and damage the pancreatic islet remains
intriguing [37]. Still, themechanisms bywhich exercisemight
be responsible for these effects need to be elucidated.
An alternate explanation would be that the selected
intensity/amount of exercise for this running study was
revealed to be too stressful for this NOD mouse model and
therefore inappropriate to test the working hypothesis and
meet the soft and hard endpoints [38, 39].
Our explorative studies set the base to further evaluate
the implementation of likely exercise protocols alongwith the
dosage of several autoimmunity markers and cytokine and
chemokine profiles.
5. Conclusions
In NOD mice moderate-intensity exercise seemed to exert
glucose-lowering effects only in the late states of diabetes.
Further studies are needed to clarify the utility of the
NOD mouse model to mimic and investigate the exer-
cise effects in T1D, immunomodulation, and inflammation.
Specifically, dose-response studies in which exercise will be
administered to NOD mice at various levels of intensity will
be necessary to determine the optimal regimen of physical
exercise having clear-cut preventive effects on the develop-
ment of T1D. A better understanding of the impact of exercise
on immune function will be of assistance in designing
improved treatments for patients with autoimmune diabetes
in the clinical arena.
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